Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nutrients|July 2, 2021
Vitamin D Metabolites and Clinical Outcome in Hospitalized COVID-19 PatientsSieglinde Zelzer, Florian Prüller, Pero Curcic, et al.
Antioxidants (Basel, Switzerland)|October 27, 2022
Low HDL Cholesterol Efflux Capacity Indicates a Fatal Course of COVID-19Julia T Stadler, Harald Mangge, Alankrita Rani, et al.
Interactive Cardiovascular and Thoracic Surgery|March 25, 2011
Pulmonary valve replacement with mechanical prostheses in re-do Fallot patientsIsmar Ovcina, Igor Knez, Pero Curcic, et al.
Antioxidants (Basel, Switzerland)|July 27, 2022
Dramatic Decrease of Vitamin K2 Subtype Menaquinone-7 in COVID-19 PatientsHarald Mangge, Florian Prueller, Christine Dawczynski, et al.
Antioxidants (Basel, Switzerland)|December 24, 2021
Increased Kynurenine Indicates a Fatal Course of COVID-19Harald Mangge, Markus Herrmann, Andreas Meinitzer, et al.
Acta Dermato-Venereologica|November 20, 2010
Tolerability and safety of biological therapies for psoriasis in daily clinical practice: a study of 103 Italian patientsAlexandra M G Brunasso, Matteo Puntoni, Camilla Salvini, et al.
Lung|July 14, 2025
Soluble Transferrin Receptor-1 in Pulmonary Hypertension Associated with COPDOleh Myronenko, Pero Curcic, Philipp Douschan, et al.
Cardiovascular Diabetology|July 20, 2023
Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trialFaisal Aziz, Norbert J Tripolt, Peter N Pferschy, et al.
Clinical Chemistry|October 5, 2023
Functional Assessment of Vitamin D Status by a Novel Metabolic Approach: The Low Vitamin D Profile ConceptMarkus Herrmann, Sieglinde Zelzer, Etienne Cavalier, et al.
Cardiovascular Diabetology|July 5, 2023
Impact of the SGLT2-inhibitor empagliflozin on inflammatory biomarkers after acute myocardial infarction - a post-hoc analysis of the EMMY trialMartin Benedikt, Harald Mangge, Faisal Aziz, et al.
Pageof 2